Body composition and nutrition can influence the management of hidradenitis suppurativa. A balanced, nutrient-rich diet can help manage weight and regulate the inflammation behind HS by providing ...

T reating hidradenitis suppurativa (HS) isn’t always easy, especially for people with moderate-to-severe cases. Currently, there’s only one type of medication — a class of drugs called ...

Hidradenitis suppurativa can be very uncomfortable, causing painful bumps under the skin, often in areas where the skin rubs together. While there is no cure for HS, there are many treatment ...

Hidradenitis Suppurativa, or HS, is a chronic disease that affects your hair follicles. Most people don't report symptoms at first. That's because most people don't think their symptoms are signs ...

Whether you’re newly diagnosed or unhappy with your current hidradenitis suppurativa treatment, a dermatologist who listens is key to getting the care you need. People with HS might not get a ...

The guidelines are a first-of-its-kind effort to establish recommendations for the medical management of HS in seven different scenarios: Pregnancy, breastfeeding, pediatrics, malignancy, tuberculosis ...

Hidradenitis suppurativa is managed with biologics like adalimumab and secukinumab, approved for moderate-to-severe cases. Adalimumab, a TNF-α inhibitor, was FDA-approved in 2015, while ...

Patients with hidradenitis suppurativa experience knowledge gaps on effective treatments and addressing these gaps could help prevent tissue damage among these patients. Hidradenitis suppurativa ...

A cohort study suggests that people with hidradenitis suppurativa (HS) have twice the incidence of noninfectious uveitis (NIU) as controls, an association that remained significant after adjusting ...

The following is a summary of “Exploring itch in hidradenitis suppurativa with lessons from atopic dermatitis and psoriasis,” published in the January 2025 issue of Dermatology by Trupiano et al. Itch ...

Opens in a new tab or window Serum level of inflammatory marker C-reactive protein (CRP) predicted response to adalimumab (Humira) treatment for patients with hidradenitis suppurativa, post hoc ...